Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Taysha Gene Therapies, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 65 | 71 | +6 |
| Shares | 18.5M | 17.0M | −1.49M (−8.0%) |
| Value | $215.6M | $110.9M | −$104.7M (−48.6%) |
New holders (15)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 250,500 | $1.63M | 0.00% |
| D. E. Shaw & Co., Inc. | 74,734 | $487.0K | 0.00% |
| 1623 Capital LLC | 46,763 | $305.0K | 0.16% |
| Thompson Siegel & Walmsley LLC | 42,100 | $274.0K | 0.00% |
| Barclays PLC | 44,387 | $273.0K | 0.00% |
| Occudo Quantitative Strategies LP | 26,328 | $172.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 20,000 | $131.0K | 0.00% |
| Nisa Investment Advisors, LLC | 19,800 | $129.0K | 0.00% |
| Parametric Portfolio Associates LLC | 18,928 | $123.0K | 0.00% |
| Caption Management, LLC | 18,191 | $119.0K | 0.01% |
| Sargent Investment Group, LLC | 10,656 | $69.0K | 0.02% |
| Amalgamated Bank | 3,535 | $23.0K | 0.00% |
| Amalgamated Financial Corp. | 3,535 | $23.0K | 0.00% |
| Signaturefd, LLC | 165 | $1.00K | 0.00% |
| Tarbox Family Office, Inc. | 175 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| University of Texas/Texas Am Investment Managment Co | 1,147,040 | $13.4M |
| Millennium Management LLC | 60,049 | $700.0K |
| Squarepoint Ops LLC | 29,210 | $340.0K |
| ProShare Advisors LLC | 10,368 | $121.0K |
| MetLife Investment Management | 9,509 | $110.8K |
| Metropolitan Life Insurance Co | 7,280 | $84.8K |
| US Bancorp | 524 | $6.00K |
| Parallel Advisors, LLC | 45 | $1.00K |
| CWM, LLC | 25 | $0 |